Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry

BACKGROUND: Where health economic studies are frequently performed using modelling, with input from randomized controlled trials and best guesses, we used real-life data to analyse the cost-effectiveness and cost-utility of a treatment strategy aiming to the target of remission compared to usual car...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Vermeer, Marloes, Kievit, Wietske, Kuper, Hillechiena H, Braakman-Jansen, Louise MA, Bernelot Moens, Hein J, Zijlstra, Theo R, den Broeder, Alfons A, van Riel, Piet LCM, Fransen, Jaap, van de Laar, Mart AFJ
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3884120/
https://ncbi.nlm.nih.gov/pubmed/24330489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-14-350
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak